On May 25, 2023, Pharosgen Co., Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,440 KRW | -2.75% | -.--% | -11.32% |
1st Jan change | Capi. | |
---|---|---|
-11.32% | 129M | |
+34.00% | 704B | |
+29.29% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+13.79% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |
- Stock Market
- Equities
- A214390 Stock
- News Kyongbo Pharmaceutical Co., Ltd
- Pharosgen Co., Ltd. announced that it has received KRW 1.999997692 billion in funding from Kyongbo Pharmaceutical Co., Ltd